Teva Pharmaceutical Industries Ltd. and AbbVie Inc. have finalized the terms of settlements worth more than $6.6 billion to resolve thousands of lawsuits by U.S. state and local governments over the marketing of opioid painkillers, the companies and lawyers for …
AbbVie Inc.’s Allergan unit has reached an agreement to pay more than $2 billion to resolve thousands of lawsuits filed by state and local governments over the marketing of its Kadian opioid painkiller, according to people familiar with the matter. …
AbbVie Inc. agreed to pay $200 million to settle claims by New York that its Allergan unit helped fuel an epidemic of opioid addiction in the state, shortly before jurors heard closing arguments from remaining defendant Teva Pharmaceutical Industries Ltd. …
A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc. in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. U.S. …
A federal jury in Chicago on Friday found AbbVie Inc. not liable in a lawsuit by an Arizona man who claimed he had suffered a pulmonary embolism due to using the company’s testosterone replacement medication AndroGel. The verdict in the …
Bob Kelsey can’t afford a cancer drug that could save his life. The retired firefighter, 53, needs Revlimid to stay healthy. Celgene Corp. has raised the price 88 percent over the past seven years. The drug doesn’t have substantial competition …
A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc. that was the first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel. U.S. District Judge Matthew Kennelly …
Federal jurors in Chicago say the pharmaceutical company AbbVie should pay $150 million to an Oregon man for misrepresenting the risks of a low testosterone treatment. The Chicago Tribune reports that the jury arrived at the figure for punitive damages …
A federal jury in East St. Louis, Ill., has awarded $15 million to a 10-year-old boy whose mother blamed his birth defect on AbbVie Inc.’s bipolar disorder drug Depakote that she took while pregnant, in the latest trial among hundreds …
The U.S. Treasury Department is examining unilateral actions to curb corporate inversions, reversing its position that only Congress has the authority to stop or slow the deals. About three weeks after Secretary Jacob J. Lew said officials had scoured “obscure …
